#White coat
Bayó J, Dalfó A, Barceló MA, Saez M, Roca C, Pallozzi J, Coll-de-Tuero G. American Journal of Hypertension 2020; 33(2): 156-160. doi: 10.1093/ajh/hpz178 (Impact Factor: 2.689, PERIPHERAL VASCULAR DISEASE, 41/65 Q3)
Coll-de-Tuero G, Saez M, Rodríguez-Poncelas A, Bayó-Llibre J, Beltrán-Vilella M, Reyes-Negre C, Dalfó-Baqué A, Barceló MA. Medicine 2019; 98(1):e14817. doi: 10.1097/MD.0000000000014817 (Impact Factor: 1.870, MEDICINE, GENERAL & INTERNAL, 69/160 Q2)
Coll-de-Tuero G, Sanmartín M, Vargas S, Trèmols S, Saez M, Barceló MA. Blood Pressure 2004; 13:164-168. doi: 10.1080/08037050410033286 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)
Coll-de-Tuero G, Foguet Q, Rodríguez-Poncelas A, Sanmartín M, Saez M, Barceló MA, VAMPAHICA Study Group. Atención Primaria 2006; 37(6):355-359. doi: 10.1157/13086703 (Impact Factor: 1.346, MEDICINE, GENERAL & INTERNAL 88/160 Q3)
Coll-de-Tuero G, Foguet Q, Rodríguez-Poncelas A, Salleras N, Saez M, Barceló MA, VAMPAHICA Study Group. Blood Pressure 2006; 15(4):227-236. doi: 10.1080/08037050600912203 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)
Foguet-Borau Q, Coll-de-Tuero G, Rodríguez-Poncelas A, Sanmartín-Albertos M, Saez M, Barceló MA, Pena-Seijo M, Pose-Reino A. Blood Pressure 2007; 16:354-361. doi: 10.1080/08037050701538089 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)
Coll-de-Tuero G, Foguet-Boreu Q, Rodríguez-Poncelas A, Creus-Bosch R, Sanmartín-Albertos M, Saez M, Barceló MA, Salleras-Marcó N. Medicina Clínica 2008; 130(9):321-326. doi: 10.1157/13117348 (Impact Factor: 1.277, MEDICINE, GENERAL & INTERNAL 91/160 Q3)
Coll-de-Tuero G, Barceló MA, Saez M. Blood Pressure 2009; 18(4):213-222. doi: 10.1080/08037050903145923 (Impact Factor: 1.656, PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 79/162 Q2)
Coll-de-Tuero G, Saez M, Rodríguez-Poncelas A, Barceló MA, Vargas-Vila S, Garré-Olmo J, Sala V, Sieira A, Gelada E, Gelado-Ferrero J. Blood Pressure 2012; 21(3):182-190. doi: 10.3109/08037051.2012.681109 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)